Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer |
| |
Authors: | Pan Xin Zhou Tao Tai Yan-Hong Wang Chenguang Zhao Jie Cao Yuan Chen Yuan Zhang Pei-Jing Yu Ming Zhen Cheng Mu Rui Bai Zhao-Fang Li Hui-Yan Li Ai-Ling Liang Bing Jian Zhao Zhang Wei-Na Man Jiang-Hong Gao Yan-Fei Gong Wei-Li Wei Li-Xin Zhang Xue-Min |
| |
Affiliation: | State Key Laboratory of Proteomics, Institute of Basic Medical Sciences, China National Center of Biomedical Analysis, Beijing, China. |
| |
Abstract: | Endocrine resistance is a major obstacle to hormonal therapy for breast cancers. Although reduced expression of estrogen receptor-α (ER-α) is a known contributing factor to endocrine resistance, the mechanism of ER-α downregulation in endocrine resistance is still not fully understood. Here we report that CUE domain-containing protein-2 (CUEDC2), a ubiquitin-binding motif-containing protein, is a key factor in endocrine resistance in breast cancer. We show that CUEDC2 modulates ER-α protein stability through the ubiquitin-proteasome pathway. Through the study of specimens from a large cohort of subjects with breast cancer, we found a strong inverse correlation between CUEDC2 and ER-α protein expression. Notably, subjects with tumors that highly expressed CUEDC2 had poor responsiveness to tamoxifen treatment and high potential for relapse. We further show that ectopic CUEDC2 expression impaired the responsiveness of breast cancer cells to tamoxifen. Therefore, our findings suggest that CUEDC2 is a crucial determinant of resistance to endocrine therapies in breast cancer. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|